IQV
IQVIA HOLDINGS INC.
Key Financials
Operating Income
$2.2B
↓ 0.9%
Gross Profit
$2.6B
N/A
Net Income
$1.4B
↓ 0.9%
Revenue
$16.3B
↑ 5.9%
EPS (Diluted)
$7.84
↑ 4.7%
Total Assets
$29.9B
↑ 11.3%
Total Liabilities
$23.3B
↑ 11.9%
Shareholders' Equity
$6.5B
↑ 7.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 5/11/2026 | View on SEC |
| 4 | 5/11/2026 | View on SEC |
| 4 | 5/11/2026 | View on SEC |
| 4 | 5/11/2026 | View on SEC |
| 8-K | 5/7/2026 | View on SEC |
| 10-Q | 5/5/2026 | View on SEC |
| 8-K | 5/5/2026 | View on SEC |
| SCHEDULE 13G | 4/30/2026 | View on SEC |
| 4 | 4/27/2026 | View on SEC |
| 4 | 4/27/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | IQV |
| Company Name | IQVIA HOLDINGS INC. |
| CIK | 1478242 |
| Sector | Services-Commercial Physical & Biological Research |
| Industry | Large accelerated filer |
| Exchange | NYSE |
| SIC Code | 8731 |
| SIC Description | Services-Commercial Physical & Biological Research |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 919-998-2000 |